BayBridge Capital Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-745
Closed -$224K 102
2024
Q4
$224K Sell
745
-2,740
-79% -$958K 0.16% 89
2024
Q3
$1.42M Buy
3,485
+35
+1% +$12.8K 1.02% 23
2024
Q2
$1.11M Buy
3,450
+83
+2% +$27K 0.87% 41
2024
Q1
$1.04M Buy
3,367
+88
+3% +$26.9K 0.91% 39
2023
Q4
$925K Buy
+3,279
New +$810K 0.86% 41

Other funds holding HCA

BayBridge Capital Group's HCA Position: Q1 2025 in Review

BayBridge Capital Group sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 745 shares — an estimated $224K sold.

BayBridge Capital Group first reported a position in HCA in Q4 2023 and held it in 5 quarters. The position peaked at $1.42M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • BayBridge Capital Group reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • BayBridge Capital Group sold 745 HCA Healthcare shares in Q1 2025, an estimated $224K.
  • BayBridge Capital Group first reported a position in HCA Healthcare in Q4 2023 and held it in 5 quarters.
  • BayBridge Capital Group's HCA Healthcare position peaked at $1.42M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on BayBridge Capital Group's 13F filing for Q1 2025, filed 17 Apr 2025.